The Emeco FY19 result just sent its share price down by 10%

The share price of Emeco Holdings Limited (ASX:EHL) has dropped 10% in response to the FY19 report.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The share price of Emeco Holdings Limited (ASX: EHL) has dropped 10% in response to the FY19 result.

Operating revenue increased by a pleasing 22% to $464.5 million and the heavy earthmoving equipment business reported that operating earnings before interest, tax, depreciation and amortisation (EBITDA) rose by 40% to $214 million. The EBITDA profit margin increased by 590 basis points (or 5.9%) to 46.1%.

Operating earnings before interest and tax (EBIT) increased by 51% to $125.4 million with a good increase of the EBIT profit margin, which rose by 520 basis points (or 5.2%) to 27%.

Emeco's operating net profit after tax (NPAT) rose by 214% to $63.1 million and statutory NPAT jumped by 536% to $33.7 million. According to Bloomberg, the market was expecting a net profit result of $54.18 million.

The growth of profit was driven by a continued increase in average operating utilisation to 64% (up from 58% in the prior year), improvement in the rental rates, continued tight cost control and a full year contribution from Force and Matilda Equipment.

Emeco generated $90.1 million of operating free cash flow before growth capital expenditure, which enabled it to repay US$33.8 million of its 9.25% senior notes and invest in strategic growth assets to future earnings. Emeco deleveraged to 2x by the end of FY19, down from 2.6x in FY18. This is calculated as net debt / operating EBITDA. Clearly deleveraging is a good thing for the strength of the business. 

For FY20 the objective set by management is to continue deleveraging by growing earnings and using cashflow to reduce debt. This will allow the company to refinance its debts on materially better terms at the optimal time.

Management also referenced strong demand in iron ore and gold projects in the west as a reason to be excited by significant opportunities to enhance commodity diversification.

Whilst Emeco is theoretically a bit less volatile the commodity businesses, and it reported an impressive result today, I don't like the idea of owning its shares because of how dependent it is on the large cyclical resource clients.

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

A man in a suit smiles at the yellow piggy bank he holds in his hand.
Share Market News

Forget Westpac shares, these ASX ETFs could be better buys

Here's why these funds could be quality picks for investors looking for alternatives to the banks.

Read more »

A male investor wearing a white shirt and blue suit jacket sits at his desk looking at his laptop with his hands to his chin, waiting in anticipation.
Share Gainers

Here are the top 10 ASX 200 shares today

It was another tough day for investors.

Read more »

Rising real estate share price.
REITs

Macquarie names its top 4 ASX REITs to buy today

Macquarie expects these four dividend paying ASX REITs will all surge higher in 2026.

Read more »

A doctor or medical expert in COVID protection adjusts her glasses, indicating growth or strong share price movement in ASX medical, biotech and health companies
Opinions

Forget CSL shares, I'd buy this booming biotech stock instead

This ASX biotech stock has caught my eye this year.

Read more »

Man with virtual white circles on his eye and AI written on top, symbolising artificial intelligence.
Broker Notes

Why this ASX AI stock could return 40% in 2026

Let's see which stock Bell Potter is tipping to rise strongly.

Read more »

A medical researcher rests his forehead on his fist with a dejected look on his face while sitting behind a scientific microscope with another researcher's hand on his shoulder as if giving comfort.
Healthcare Shares

Telix Pharmaceuticals shares crash 58% from their peak: Buying opportunity or time to sell up?

The biopharmaceutical company's shares are tipped to soar next year.

Read more »

Red buy button on an apple keyboard with a finger on it representing asx tech shares to buy today
Share Market News

Analysts name 2 top ASX 200 shares to buy today

Leading investment experts name two quality ASX 200 shares to buy now.

Read more »

Woman leaping in the air and standing out from her friends who are watching.
Broker Notes

This ASX 200 gold stock has surged 77% in 2025. Here's why Macquarie expects it to leap another 23%

Macquarie forecasts 23% upside for this surging ASX gold stock, and that doesn’t include the dividends!

Read more »